Rigaud O, Moustacchi E
Institut Curie-Biologie, Paris, France.
Cancer Res. 1994 Apr 1;54(7 Suppl):1924s-1928s.
A 70% reduction of HPRT- mutant frequency in radioadapted human lymphoblastoid cells has been reported, as analyzed by the Southern blot method (O. Rigaud et al., Radiat. Res., 133: 94-101, 1993). The data reported here extend the previous molecular analysis to a collection of 118 mutants. Structural rearrangements of the HPRT gene were determined using the multiplex polymerase chain reaction assay. This allows us to define more precisely the deleted exons in mutants and to ensure the absence of small alterations in exons among mutants with no detectable change after Southern analysis. The phenotype of these latter mutants is likely to be due to point mutations. Overall results of both Southern and multiplex polymerase chain reaction analyses confirm that the proportion of deletion-type mutations is decreased in adapted cells (42%) compared to that in mutants treated with the high dose alone (77%). Mutants with no change at the HPRT gene level were further characterized with respect to their HPRT gene expression. The vast majority of adapted mutants (86%) were still expressing mRNA, whereas HPRT transcripts were detected in only 56% of the mutants induced by the high dose alone. From these data and those reported by others, possible mechanisms underlying the adaptive response are proposed.
据报道,采用Southern印迹法分析发现,经辐射适应的人淋巴母细胞中HPRT突变频率降低了70%(O. Rigaud等人,《辐射研究》,第133卷,第94 - 101页,1993年)。本文报告的数据将先前的分子分析扩展到了118个突变体的集合。使用多重聚合酶链反应测定法确定HPRT基因的结构重排。这使我们能够更精确地确定突变体中缺失的外显子,并确保在Southern分析后无可检测变化的突变体中外显子不存在小的改变。后一类突变体的表型可能是由于点突变引起的。Southern分析和多重聚合酶链反应分析的总体结果均证实,与仅用高剂量处理的突变体(77%)相比,适应细胞中缺失型突变的比例有所降低(42%)。对HPRT基因水平无变化的突变体进一步进行了HPRT基因表达方面的表征。绝大多数适应突变体(86%)仍在表达mRNA,而仅用高剂量诱导的突变体中只有56%检测到HPRT转录本。根据这些数据以及其他人报告的数据,提出了适应性反应潜在的可能机制。